Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (51-60 of 824) with videos related to

Pageof 83
Sort By:
Urology|March 4, 2000
Clinical states in prostate cancer: toward a dynamic model of disease progressionH I Scher, G Heller
Seminars in Urologic Oncology|May 16, 2002
Outcome predictions for patients with metastatic prostate cancerOren Smaletz, Howard I Scher
Nature Reviews. Clinical Oncology|January 11, 2012
Prostate cancer in 2011: Hitting old targets better and identifying new targetsYu Chen, Howard I Scher
Current Opinion in Oncology|May 1, 1993
Incorporating tumor biology into therapy for prostate cancerJ Bromberg, H I Scher
Neurology|August 23, 2015
Suicide risk is elevated in migraineurs who have comorbid fibromyalgiaTobias Kurth, Ann I Scher
Infection and Immunity|April 1, 1979
Endotoxin lethality and tolerance in mice: analysis with the B-lymphocyte-defective CBA/N strainN M Zaldivar, I Scher
Current Topics in Microbiology and Immunology|January 1, 1986
X-linked immune deficiency (xid) of CBA/N miceL S Wicker, I Scher
The Lancet. Oncology|July 10, 2003
Prostate cancer: a dynamic illness with shifting targetsDavid R Shaffer, Howard I Scher
Psycho-Oncology|May 20, 1998
Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancerA J Roth, H I Scher
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2007
(11)C-acetate PET imaging in prostate cancerMichael J Morris, Howard I Scher
Pageof 83

Showing results (51-60 of 824) with videos related to

Sort By:
Pageof 83
Urology|March 4, 2000
Clinical states in prostate cancer: toward a dynamic model of disease progressionH I Scher, G Heller
Seminars in Urologic Oncology|May 16, 2002
Outcome predictions for patients with metastatic prostate cancerOren Smaletz, Howard I Scher
Nature Reviews. Clinical Oncology|January 11, 2012
Prostate cancer in 2011: Hitting old targets better and identifying new targetsYu Chen, Howard I Scher
Current Opinion in Oncology|May 1, 1993
Incorporating tumor biology into therapy for prostate cancerJ Bromberg, H I Scher
Neurology|August 23, 2015
Suicide risk is elevated in migraineurs who have comorbid fibromyalgiaTobias Kurth, Ann I Scher
Infection and Immunity|April 1, 1979
Endotoxin lethality and tolerance in mice: analysis with the B-lymphocyte-defective CBA/N strainN M Zaldivar, I Scher
Current Topics in Microbiology and Immunology|January 1, 1986
X-linked immune deficiency (xid) of CBA/N miceL S Wicker, I Scher
The Lancet. Oncology|July 10, 2003
Prostate cancer: a dynamic illness with shifting targetsDavid R Shaffer, Howard I Scher
Psycho-Oncology|May 20, 1998
Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancerA J Roth, H I Scher
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2007
(11)C-acetate PET imaging in prostate cancerMichael J Morris, Howard I Scher
Pageof 83